**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 615-83-8 |DL-Ethyl 2-bromovalerate | 99 | 210-450-1 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.Lachrymator
(substance which increases the flow of tears).
Potential Health Effects
Eye:
May cause severe eye irritation. Lachrymator (substance which
increases the flow of tears). May cause chemical conjunctivitis and
corneal damage.
Skin:
May cause severe irritation and possible burns. May cause cyanosis
of the extremities.
Ingestion:
May cause severe digestive tract irritation with abdominal pain,
nausea, vomiting and diarrhea.
Inhalation:
May cause severe respiratory tract irritation and possible burns.
Aspiration may lead to pulmonary edema. Inhalation at high
concentrations may cause CNS depression and asphixiation.
Chronic:
Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid. Do
NOT allow victim to rub eyes or keep eyes closed.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Combustible liquid.
Vapors may be heavier than air. They can spread along the ground and
collect in low or confined areas. Containers may explode when heated.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use water spray,
dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Cover with sand, dry lime or soda ash and place in
a closed container for disposal. Remove all sources of ignition. Use
a spark-proof tool. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Do not get in
eyes, on skin, or on clothing. Empty containers retain product
residue, (liquid and/or vapor), and can be dangerous. Keep container
tightly closed. Keep away from heat, sparks and flame. Do not ingest
or inhale. Do not pressurize, cut, weld, braze, solder, drill, grind,
or expose empty containers to heat, sparks or open flames. Do not
breathe vapor.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local explosion-proof ventilation to keep airborne levels to
acceptable levels.
Exposure Limits
CAS# 615-83-8:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use. Follow the OSHA
respirator regulations found in 29 CFR 1910.134 or
European Standard EN 149. Use a NIOSH/MSHA or
European Standard EN 149 approved respirator if
exposure limits are exceeded or if irritation or
other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Clear liquid
Color: clear, colorless
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 190.0 - 192.0 deg C @ 760.00m
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: 77 deg C ( 170.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: insoluble
Specific Gravity/Density: 1.2260g/cm3
Molecular Formula: C7H13BrO2
Molecular Weight: 209.08
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Acids, bases, oxidizing agents, reducing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 615-83-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
DL-Ethyl 2-bromovalerate -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 615-83-8: No information available.
Canada
CAS# 615-83-8 is listed on Canada's DSL List.
CAS# 615-83-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 615-83-8 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #6 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Diacetin (Pract), 98% (GC)
| 25395-31-7 |
|
D-(+)-Ribonic acid gamma-lactone, 96%
| 5336-08-3 |
|
Gamma-Valerolactone, 98%
| 108-29-2 |
|
Tri-Normal-Octylamine, 98%
| 1116-76-3 |
|
1,8-Diazabicyclo[5.4.0]undec-7-ene, 98%
| 6674-22-2 |
|
2-Phenyl-4-Quinolinecarboxylic Acid, 99%
| 132-60-5 |
|
Methylnorbornene-2,3-dicarboxylic anhydride 95%, mixture of isomers
| 25134-21-8 |
|
Ruthenium, powder,-200 mesh, 99.9%
| 7440-18-8 |
|
Lauryl gallate, 96+%
| 1166-52-5 |
|
2-Chloro-4-fluoro-5-methylaniline, 99.5+%
| 116759-33-2 |
|
Glycolic acid, 67% in water
| 79-14-1 |
|
Methyl Green, zinc chloride salt, high purity biological stain
| 7114-03-6 |
|
Rubidium Hydroxide, 99.9%, 50 wt% Solution in Water
| 1310-82-3 |
|
3-Iodopropionic Acid, 98%
| 141-76-4 |
|
Adenosine 5'-triphosphate disodium salt, trihydrate, 99% (HPLC)
| 987-65-5 |
|
Methyl-d3-amine hydrochloride, 98+ atom % D
| 593-51-1 |
|
Esculin Monohydrate, 97%
| 531-75-9 |
|
Quinoline Yellow, Spirit Soluble, 95%
| 8003-22-3 |
|
Pseudothiohydantoin, 97%
| 556-90-1 |
|
DL-Ethyl 2-bromovalerate, 99%
| 615-83-8 |
|
Calcium oxalate monohydrate, 98%
| 563-72-4 |
|
Potassium formate (pract)
| 590-29-4 |
|
4-Acetylpyridine, 98%
| 1122-54-9 |
|
4-Phosphonooxy-tempo hydrate, free radical
| 22690-04-6 |
|
4-Decylbenzoyl Chloride, 98% (Titr.)
| 54256-43-8 |
|
Trichloroacetyl chloride
| 76-02-8 |
|
3-Carbamoyl-2,2,5,5-tetramethyl-3- pyrrolin-1-yloxy, free radical
| 3229-73-0 |
|
2-Thiophenesulfonyl chloride
| 16629-19-9 |
|
1,10-Diiododecane, 97%
| 16355-92-3 |
|
2,3,4-Trihydroxybenzaldehyde, 98% (titr.)
| 2144-08-3 |
|
Thulium atomic absorption standard solution, 1 mg/ml Tm in 2% HNO3
| 7440-30-4 |
|
Sodium Polyanetholesulfonate
| 52993-95-0 |
|
Tetraphenylphosphonium Iodide, 99%
| 2065-67-0 |
|
2,3-Dichloro-1-propene, 98%
| 78-88-6 |
|
N-Cyanoimido-S,S-Dimethyl-Dithiocarbonate ca. 90%, Remainder Water
| 7732-18-5 |
|
9-Fluorenone-2-Carboxylic Acid, 97% (GC)
| 784-50-9 |
|
3-(3,4-Dimethoxyphenyl)-Propionic Acid, 99%
| 2107-70-2 |
|
1-Phenyl-1,3,8-Triazaspiro(4,5) Decan-- 4-One, 95% (TLC)
| 1021-25-6 |
|
Cycloheptylamine, 99%
| 5452-35-7 |
|
3,3-Dimethylglutarimide, 99%
| 1123-40-6 |
|
Alpha-d-Methylglucoside, 99%
| 97-30-3 |
|
D-(-)-2-Aminobutyric Acid, 99+%
| 2623-91-8 |
|
3-Hydroxytetrahydrofuran, 97%
| 453-20-3 |
|
p-Aminohippuric acid, sodium salt, monohydrate 98%
| 94-16-6 |
|
Pentafluorobenzoic acid, 99%
| 602-94-8 |
|
Anthraquinone-2-sulfonic acid, sodium salt monohydrate, 90%
| 131-08-8 |
|
5-Chlorosalicylic acid, 98%
| 321-14-2 |
|
Fluoranthene, 98%
| 206-44-0 |
|
N-(4-Methoxybenzylidene)-4-Butylaniline, 99% (Titr.)
| 26227-73-6 |
|
Hydroxypropyl Methyl Cellulose
| 9004-65-3 |
|
|